InstitutionMD Anderson
DepartmentPulmonary Medicine
Address2121 Holcombe Blvd
Houston TX 77030-4244
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cho MS, Li J, Gonzalez-Delgado R, Lee H, Vasquez M, He T, He Y, Liu K, Sasano T, Nürnberg B, Sood AK, Wong STC, Afshar-Kharghan V. The effect of platelet G proteins on platelet extravasation and tumor growth in the murine model of ovarian cancer. Blood Adv. 2021 Apr 13; 5(7):1947-1951. PMID: 33821990.
    2. Oncul S, Afshar-Kharghan V. The interaction between the complement system and hemostatic factors. Curr Opin Hematol. 2020 09; 27(5):341-352. PMID: 32701617.
      Citations:    Fields:    Translation:Humans
    3. Saha B, Mathur T, Handley KF, Hu W, Afshar-Kharghan V, Sood AK, Jain A. OvCa-Chip microsystem recreates vascular endothelium-mediated platelet extravasation in ovarian cancer. Blood Adv. 2020 07 28; 4(14):3329-3342. PMID: 32717032.
      Citations:    Fields:    
    4. Afshar-Kharghan V. APC ameliorates pulmonary complications in cGVHD. Blood. 2019 08 29; 134(9):724-725. PMID: 31467078.
      Citations:    Fields:    Translation:HumansCells
    5. Ma Q, Li D, Vasquez HG, You MJ, Afshar-Kharghan V. Kidney Injury in Murine Models of Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2019 10; 25(10):1920-1924. PMID: 31271886.
      Citations:    Fields:    Translation:HumansAnimals
    6. Haemmerle M, Stone RL, Menter DG, Afshar-Kharghan V, Sood AK. The Platelet Lifeline to Cancer: Challenges and Opportunities. Cancer Cell. 2018 06 11; 33(6):965-983. PMID: 29657130.
      Citations: 56     Fields:    Translation:HumansAnimalsCells
    7. Haemmerle M, Taylor ML, Gutschner T, Pradeep S, Cho MS, Sheng J, Lyons YM, Nagaraja AS, Dood RL, Wen Y, Mangala LS, Hansen JM, Rupaimoole R, Gharpure KM, Rodriguez-Aguayo C, Yim SY, Lee JS, Ivan C, Hu W, Lopez-Berestein G, Wong ST, Karlan BY, Levine DA, Liu J, Afshar-Kharghan V, Sood AK. Platelets reduce anoikis and promote metastasis by activating YAP1 signaling. Nat Commun. 2017 08 21; 8(1):310. PMID: 28827520.
      Citations: 48     Fields:    Translation:HumansAnimalsCells
    8. Cho MS, Noh K, Haemmerle M, Li D, Park H, Hu Q, Hisamatsu T, Mitamura T, Mak SLC, Kunapuli S, Ma Q, Sood AK, Afshar-Kharghan V. Role of ADP receptors on platelets in the growth of ovarian cancer. Blood. 2017 09 07; 130(10):1235-1242. PMID: 28679740.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    9. Hu Q, Hisamatsu T, Haemmerle M, Cho MS, Pradeep S, Rupaimoole R, Rodriguez-Aguayo C, Lopez-Berestein G, Wong STC, Sood AK, Afshar-Kharghan V. Role of Platelet-Derived Tgfß1 in the Progression of Ovarian Cancer. Clin Cancer Res. 2017 Sep 15; 23(18):5611-5621. PMID: 28611202.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    10. Afshar-Kharghan V. Complement and clot. Blood. 2017 04 20; 129(16):2214-2215. PMID: 28428238.
      Citations: 3     Fields:    Translation:Humans
    11. Afshar-Kharghan V. The role of the complement system in cancer. J Clin Invest. 2017 Mar 01; 127(3):780-789. PMID: 28248200.
      Citations: 89     Fields:    Translation:HumansAnimalsCells
    12. Afshar-Kharghan V. Atypical hemolytic uremic syndrome. Hematology Am Soc Hematol Educ Program. 2016 Dec 02; 2016(1):217-225. PMID: 27913483.
      Citations: 7     Fields:    Translation:Humans
    13. Hu Q, Cho MS, Thiagarajan P, Aung FM, Sood AK, Afshar-Kharghan V. A small amount of cyclooxygenase 2 (COX2) is constitutively expressed in platelets. Platelets. 2017 Jan; 28(1):99-102. PMID: 27534811.
      Citations: 3     Fields:    Translation:HumansCells
    14. Hu Q, Wang M, Cho MS, Wang C, Nick AM, Thiagarajan P, Aung FM, Han X, Sood AK, Afshar-Kharghan V. Lipid profile of platelets and platelet-derived microparticles in ovarian cancer. BBA Clin. 2016 Dec; 6:76-81. PMID: 27453821.
      Citations: 9     
    15. Feng S, Kroll MH, Nick AM, Sood AK, Afshar-Kharghan V. Platelets are not hyperreactive in patients with ovarian cancer. Platelets. 2016 Nov; 27(7):716-718. PMID: 27185008.
      Citations: 4     Fields:    Translation:HumansCells
    16. Haemmerle M, Bottsford-Miller J, Pradeep S, Taylor ML, Choi HJ, Hansen JM, Dalton HJ, Stone RL, Cho MS, Nick AM, Nagaraja AS, Gutschner T, Gharpure KM, Mangala LS, Rupaimoole R, Han HD, Zand B, Armaiz-Pena GN, Wu SY, Pecot CV, Burns AR, Lopez-Berestein G, Afshar-Kharghan V, Sood AK. FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal. J Clin Invest. 2016 05 02; 126(5):1885-96. PMID: 27064283.
      Citations: 31     Fields:    Translation:HumansAnimalsCells
    17. Cho MS, Rupaimoole R, Choi HJ, Noh K, Chen J, Hu Q, Sood AK, Afshar-Kharghan V. Complement Component 3 Is Regulated by TWIST1 and Mediates Epithelial-Mesenchymal Transition. J Immunol. 2016 Feb 01; 196(3):1412-8. PMID: 26718342.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    18. Wang R, Stone RL, Kaelber JT, Rochat RH, Nick AM, Vijayan KV, Afshar-Kharghan V, Schmid MF, Dong JF, Sood AK, Chiu W. Electron cryotomography reveals ultrastructure alterations in platelets from patients with ovarian cancer. Proc Natl Acad Sci U S A. 2015 Nov 17; 112(46):14266-71. PMID: 26578771.
      Citations: 17     Fields:    Translation:HumansCellsCTClinical Trials
    19. Ciurea SO, Thall PF, Milton DR, Barnes TH, Kongtim P, Carmazzi Y, López AA, Yap DY, Popat U, Rondon G, Lichtiger B, Aung F, Afshar-Kharghan V, Ma Q, Fernández-Viña M, Champlin RE, Cao K. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2015 Aug; 21(8):1392-8. PMID: 25985919.
      Citations: 25     Fields:    Translation:Humans
    20. Pemmaraju N, Sasaki K, Johnson D, Daver N, Afshar-Kharghan V, Chen M, Ahmed S, Colen RR, Kwon M, Huh Y, Borthakur G. Successful Treatment of Intracranial Hemorrhage with Recombinant Activated Factor VII in a Patient with Newly Diagnosed Acute Myeloid Leukemia: A Case Report and Review of the Literature. Front Oncol. 2015; 5:29. PMID: 25717439.
      Citations: 1     
    21. Bottsford-Miller J, Choi HJ, Dalton HJ, Stone RL, Cho MS, Haemmerle M, Nick AM, Pradeep S, Zand B, Previs RA, Pecot CV, Crane EK, Hu W, Lutgendorf SK, Afshar-Kharghan V, Sood AK. Differential platelet levels affect response to taxane-based therapy in ovarian cancer. Clin Cancer Res. 2015 Feb 01; 21(3):602-10. PMID: 25473001.
      Citations: 31     Fields:    Translation:HumansAnimalsCells
    22. Feng S, Liang X, Kroll MH, Chung DW, Afshar-Kharghan V. von Willebrand factor is a cofactor in complement regulation. Blood. 2015 Feb 05; 125(6):1034-7. PMID: 25395424.
      Citations: 16     Fields:    Translation:HumansCells
    23. Afshar-Kharghan V. COMPLEMENTing the diagnosis of aHUS. Blood. 2014 Sep 11; 124(11):1699-700. PMID: 25214194.
      Citations:    Fields:    Translation:Humans
    24. Wu W, Merriman K, Nabaah A, Seval N, Afshar-Kharghan V, Yeung SC. Heparin-induced thrombocytopenia among patients of a comprehensive cancer center. SAGE Open Med Case Rep. 2014; 2:2050313X14533945. PMID: 27489647.
      Citations: 1     
    25. Lin RJ, Afshar-Kharghan V, Schafer AI. Paraneoplastic thrombocytosis: the secrets of tumor self-promotion. Blood. 2014 Jul 10; 124(2):184-7. PMID: 24868077.
      Citations: 35     Fields:    Translation:HumansAnimalsCells
    26. Ma Q, Li D, Carreño R, Patenia R, Tsai KY, Xydes-Smith M, Alousi AM, Champlin RE, Sale GE, Afshar-Kharghan V. Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD. Bone Marrow Transplant. 2014 Jul; 49(7):972-6. PMID: 24777193.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    27. Davis AN, Afshar-Kharghan V, Sood AK. Platelet effects on ovarian cancer. Semin Oncol. 2014 Jun; 41(3):378-84. PMID: 25023353.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    28. Cho MS, Vasquez HG, Rupaimoole R, Pradeep S, Wu S, Zand B, Han HD, Rodriguez-Aguayo C, Bottsford-Miller J, Huang J, Miyake T, Choi HJ, Dalton HJ, Ivan C, Baggerly K, Lopez-Berestein G, Sood AK, Afshar-Kharghan V. Autocrine effects of tumor-derived complement. Cell Rep. 2014 Mar 27; 6(6):1085-1095. PMID: 24613353.
      Citations: 67     Fields:    Translation:HumansAnimalsCells
    29. Nolasco L, Nolasco J, Feng S, Afshar-Kharghan V, Moake J. Human complement factor H is a reductase for large soluble von Willebrand factor multimers--brief report. Arterioscler Thromb Vasc Biol. 2013 Nov; 33(11):2524-8. PMID: 24008159.
      Citations: 12     Fields:    Translation:HumansCells
    30. Feng S, Liang X, Cruz MA, Vu H, Zhou Z, Pemmaraju N, Dong JF, Kroll MH, Afshar-Kharghan V. The interaction between factor H and Von Willebrand factor. PLoS One. 2013; 8(8):e73715. PMID: 23991205.
      Citations: 14     Fields:    Translation:HumansCells
    31. Feng S, Eyler SJ, Zhang Y, Maga T, Nester CM, Kroll MH, Smith RJ, Afshar-Kharghan V. Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome. Blood. 2013 Aug 22; 122(8):1487-93. PMID: 23847193.
      Citations: 27     Fields:    Translation:Humans
    32. Thiagarajan P, Afshar-Kharghan V. Platelet transfusion therapy. Hematol Oncol Clin North Am. 2013 Jun; 27(3):629-43. PMID: 23714315.
      Citations: 6     Fields:    Translation:HumansCells
    33. Feng S, Kroll MH, Nolasco L, Moake J, Afshar-Kharghan V. Complement activation in thrombotic microangiopathies. Br J Haematol. 2013 Feb; 160(3):404-6. PMID: 23116127.
      Citations: 5     Fields:    Translation:Humans
    34. Cho MS, Bottsford-Miller J, Vasquez HG, Stone R, Zand B, Kroll MH, Sood AK, Afshar-Kharghan V. Platelets increase the proliferation of ovarian cancer cells. Blood. 2012 Dec 06; 120(24):4869-72. PMID: 22966171.
      Citations: 72     Fields:    Translation:HumansAnimalsCells
    35. Kroll MH, Afshar-Kharghan V. Platelets in pulmonary vascular physiology and pathology. Pulm Circ. 2012 Jul; 2(3):291-308. PMID: 23130099.
      Citations: 5     
    36. Ma Q, Li D, Nurieva R, Patenia R, Bassett R, Cao W, Alekseev AM, He H, Molldrem JJ, Kroll MH, Champlin RE, Sale GE, Afshar-Kharghan V. Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation. Biol Blood Marrow Transplant. 2012 Aug; 18(8):1174-81. PMID: 22664751.
      Citations: 10     Fields:    Translation:AnimalsCells
    37. Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, Rupairmoole R, Armaiz-Pena GN, Pecot CV, Coward J, Deavers MT, Vasquez HG, Urbauer D, Landen CN, Hu W, Gershenson H, Matsuo K, Shahzad MM, King ER, Tekedereli I, Ozpolat B, Ahn EH, Bond VK, Wang R, Drew AF, Gushiken F, Lamkin D, Collins K, DeGeest K, Lutgendorf SK, Chiu W, Lopez-Berestein G, Afshar-Kharghan V, Sood AK. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012 Feb 16; 366(7):610-8. PMID: 22335738.
      Citations: 222     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    38. Zalpour A, Kroll MH, Afshar-Kharghan V, Yusuf SW, Escalante C. Role of factor xa inhibitors in cancer-associated thrombosis: any new data? Adv Hematol. 2011; 2011:196135. PMID: 22013445.
      Citations: 2     
    39. Divakaran V, Mehta S, Yao D, Hassan S, Simpson S, Wiegerinck E, Swinkels DW, Mann DL, Afshar-Kharghan V. Hepcidin in anemia of chronic heart failure. Am J Hematol. 2011 Jan; 86(1):107-9. PMID: 21080339.
      Citations: 5     Fields:    Translation:Humans
    40. Hanzelka KM, Zalpour A, Afshar-Kharghan V, Fitousis K, Anderlini P, Yeung SC. Severe thrombosis and acute thrombocytopenia in a cancer patient. Am J Hematol. 2010 Nov; 85(11):887-90. PMID: 20721891.
      Citations: 1     Fields:    Translation:Humans
    41. Seo N, Russell BH, Rivera JJ, Liang X, Xu X, Afshar-Kharghan V, Höök M. An engineered alpha1 integrin-binding collagenous sequence. J Biol Chem. 2010 Oct 01; 285(40):31046-54. PMID: 20675378.
      Citations: 21     Fields:    Translation:HumansCells
    42. Gushiken FC, Han H, Li J, Rumbaut RE, Afshar-Kharghan V. Abnormal platelet function in C3-deficient mice. J Thromb Haemost. 2009 May; 7(5):865-70. PMID: 19291167.
      Citations: 19     Fields:    Translation:AnimalsCells
    43. Kulkarni PA, Afshar-Kharghan V. Anticomplement therapy. Biologics. 2008 Dec; 2(4):671-85. PMID: 19707448.
      Citations: 3     
    44. Mnjoyan Z, Li J, Afshar-Kharghan V. Factor H binds to platelet integrin alphaIIbbeta3. Platelets. 2008 Nov; 19(7):512-9. PMID: 18979363.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    45. Afshar-Kharghan V. Unleashed platelets in aHUS. Blood. 2008 Jun 01; 111(11):5266. PMID: 18502839.
      Citations: 2     Fields:    
    46. Jelinek J, Li J, Mnjoyan Z, Issa JP, Prchal JT, Afshar-Kharghan V. Epigenetic control of PRV-1 expression on neutrophils. Exp Hematol. 2007 Nov; 35(11):1677-83. PMID: 17976520.
      Citations: 5     Fields:    Translation:HumansCells
    47. Diz-Kucukkaya R, Inanc M, Afshar-Kharghan V, Zhang QE, López JA, Pekcelen Y. P-selectin glycoprotein ligand-1 VNTR polymorphisms and risk of thrombosis in the antiphospholipid syndrome. Ann Rheum Dis. 2007 Oct; 66(10):1378-80. PMID: 17545190.
      Citations: 6     Fields:    Translation:HumansCells
    48. Luo SZ, Mo X, Afshar-Kharghan V, Srinivasan S, López JA, Li R. Glycoprotein Ibalpha forms disulfide bonds with 2 glycoprotein Ibbeta subunits in the resting platelet. Blood. 2007 Jan 15; 109(2):603-9. PMID: 17008541.
      Citations: 48     Fields:    Translation:HumansAnimalsCells
    49. Mnjoyan Z, Yoon D, Li J, Delhommeau F, Afshar-Kharghan V. The effect of the JAK2 V617F mutation on PRV-1 expression. Haematologica. 2006 Mar; 91(3):411-2. PMID: 16503546.
      Citations: 1     Fields:    Translation:HumansCells
    50. Afshar-Kharghan V, Thiagarajan P. Leukocyte adhesion and thrombosis. Curr Opin Hematol. 2006 Jan; 13(1):34-9. PMID: 16319685.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    51. Del Conde I, Crúz MA, Zhang H, López JA, Afshar-Kharghan V. Platelet activation leads to activation and propagation of the complement system. J Exp Med. 2005 Mar 21; 201(6):871-9. PMID: 15781579.
      Citations: 106     Fields:    Translation:HumansAnimalsCells
    52. Mnjoyan Z, Li J, Afshar-Kharghan V. Expression of polycythemia rubra vera-1 decreases the dependency of cells on growth factors for proliferation. Haematologica. 2005 Mar; 90(3):405-6. PMID: 15749675.
      Citations: 1     Fields:    Translation:AnimalsCells
    53. Afshar-Kharghan V, López JA, Gray LA, Padilla A, Borthakur G, Roberts SC, Pruthi RK, Tefferi A. Hemostatic gene polymorphisms and the prevalence of thrombotic complications in polycythemia vera and essential thrombocythemia. Blood Coagul Fibrinolysis. 2004 Jan; 15(1):21-4. PMID: 15166939.
      Citations: 3     Fields:    Translation:Humans
    54. Afshar-Kharghan V, Matijevic-Aleksic N, Ahn C, Boerwinkle E, Wu KK, López JA. The variable number of tandem repeat polymorphism of platelet glycoprotein Ibalpha and risk of coronary heart disease. Blood. 2004 Feb 01; 103(3):963-5. PMID: 14592833.
      Citations: 7     Fields:    Translation:HumansCells
    55. Meisel C, Afshar-Kharghan V, Cascorbi I, Laule M, Stangl V, Felix SB, Baumann G, López JA, Roots I, Stangl K. Role of Kozak sequence polymorphism of platelet glycoprotein Ibalpha as a risk factor for coronary artery disease and catheter interventions. J Am Coll Cardiol. 2001 Oct; 38(4):1023-7. PMID: 11583876.
      Citations: 11     Fields:    Translation:Humans
    56. Baker RI, Eikelboom J, Lofthouse E, Staples N, Afshar-Kharghan V, López JA, Shen Y, Berndt MC, Hankey G. Platelet glycoprotein Ibalpha Kozak polymorphism is associated with an increased risk of ischemic stroke. Blood. 2001 Jul 01; 98(1):36-40. PMID: 11418460.
      Citations: 13     Fields:    Translation:HumansCells
    57. Afshar-Kharghan V, Diz-Küçükkaya R, Ludwig EH, Marian AJ, López JA. Human polymorphism of P-selectin glycoprotein ligand 1 attributable to variable numbers of tandem decameric repeats in the mucinlike region. Blood. 2001 May 15; 97(10):3306-7. PMID: 11342464.
      Citations: 15     Fields:    Translation:HumansCells
    58. Afshar-Kharghan V, Craig FE, López JA. Bernard-Soulier syndrome in a patient doubly heterozygous for two frameshift mutations in the glycoprotein ib alpha gene. Br J Haematol. 2000 Sep; 110(4):919-24. PMID: 11054083.
      Citations: 4     Fields:    Translation:HumansCells
    59. Afshar-Kharghan V, Gineys G, Schade AJ, Sun L, Li CQ, McIntire LV, Dong JF, López JA. Necessity of conserved asparagine residues in the leucine-rich repeats of platelet glycoprotein Ib alpha for the proper conformation and function of the ligand-binding region. Biochemistry. 2000 Mar 28; 39(12):3384-91. PMID: 10727232.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    60. Sachs UJ, Kiefel V, Böhringer M, Afshar-Kharghan V, Kroll H, Santoso S. Single amino acid substitution in human platelet glycoprotein Ibbeta is responsible for the formation of the platelet-specific alloantigen Iy(a). Blood. 2000 Mar 01; 95(5):1849-55. PMID: 10688847.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    61. Afshar-Kharghan V, Li CQ, Khoshnevis-Asl M, López JA. Kozak sequence polymorphism of the glycoprotein (GP) Ibalpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex. Blood. 1999 Jul 01; 94(1):186-91. PMID: 10381512.
      Citations: 19     Fields:    Translation:HumansCells
    62. López JA, Andrews RK, Afshar-Kharghan V, Berndt MC. Bernard-Soulier syndrome. Blood. 1998 Jun 15; 91(12):4397-418. PMID: 9616133.
      Citations: 91     Fields:    Translation:HumansCells
    63. Dong JF, Li CQ, Sae-Tung G, Hyun W, Afshar-Kharghan V, López JA. The cytoplasmic domain of glycoprotein (GP) Ibalpha constrains the lateral diffusion of the GP Ib-IX complex and modulates von Willebrand factor binding. Biochemistry. 1997 Oct 14; 36(41):12421-7. PMID: 9376345.
      Citations: 16     Fields:    Translation:HumansCells
    64. Afshar-Kharghan V, López JA. Bernard-Soulier syndrome caused by a dinucleotide deletion and reading frameshift in the region encoding the glycoprotein Ib alpha transmembrane domain. Blood. 1997 Oct 01; 90(7):2634-43. PMID: 9326230.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    65. A small amount of cyclooxygenase 2 (COX2) is constitutively expressed in platelets. Platelets. 1-4.
    66. Successful treatment of intracranial hemorrhage with recombinant activated factor VII in a patient with newly diagnosed acute myeloid leukemia. Frontiers in Oncology. 5.
    67. Electron cryotomography reveals ultrastructure alterations in platelets from patients with ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America. 112:14266-14271.
    68. Complement component 3 is regulated by TWIST1 and mediates epithelial-mesenchymal transition. Journal of Immunology. 196:1412-1418.
    69. The authors reply. New England Journal of Medicine. 366:1840.
    70. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 21:1392-1398.
    71. Platelets are not hyperreactive in patients with ovarian cancer. Platelets. 1-3.
    72. Lipid profile of platelets and platelet-derived microparticles in ovarian cancer. BBA Clinical. 6:76-81.
    73. Platelet polymorphisms. 281-307.
    74. FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal. Journal of Clinical Investigation. 126:1885-1896.
    AFSHAR-KHARGHAN's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (289)
    Co-Authors (46)
    Similar People (60)
    Same Department Expand Description